Human Milk Oligosaccharides (HMOs) offer a range of health benefits, primarily for infants. Here are some key advantages associated with the consumption of HMOs in human breast milk:

1. Promotes Healthy Gut Microbiota:

HMOs act as prebiotics, selectively promoting the growth and activity of beneficial bacteria, especially Bifidobacteria, in the infant's gut. This helps establish a balanced and healthy gut microbiota, which is essential for digestion and overall health.

2. Supports Immune System Development:

HMOs contribute to the development and maturation of the infant's immune system. They enhance the function of immune cells and help protect against infections, promoting overall immune health.

3. Anti-Inflammatory Effects:

Some HMOs have demonstrated anti-inflammatory properties, helping to modulate the inflammatory response in the gut. This may contribute to reducing the risk of inflammatory conditions and promoting a healthy gut environment.

4. Anti-Adhesive Properties:

HMOs act as decoys for pathogens by mimicking the structures of cell surface receptors. This anti-adhesive property helps prevent harmful bacteria and viruses from adhering to the infant's mucosal surfaces in the gut, reducing the risk of infections.

5. Gut Barrier Function:

HMOs contribute to the development of a strong and effective gut barrier. A healthy gut barrier prevents the passage of harmful substances from the gut into the bloodstream, protecting the infant from potential health risks.

6. Brain Development:

Certain HMOs, such as 2'-fucosyllactose (2'-FL), have been associated with cognitive development. They may play a role in supporting brain development in infants.

7. Personalized Nutrition:

The composition of HMOs in breast milk varies among individuals. This personalized variation is thought to provide infants with tailored nutrition, adapting to their specific needs and promoting optimal growth and development.

8. Metabolic Benefits:

HMOs may influence metabolic processes, contributing to the development of a healthy metabolic profile in infants.

9. Antioxidant Properties:

Some HMOs exhibit antioxidant properties, helping protect cells from oxidative stress and supporting overall cellular health.

10. Reduced Allergy Risk:

There is some evidence suggesting that exposure to certain HMOs in early life may be associated with a reduced risk of developing allergies.

Adopting enzymatic technology has significantly reduced production costs and elevated products' purity. That's a remarkable achievement that we can produce Human Milk Oligosaccharides (HMOs) products using enzymatic technology successfully. Below are 5 of HMOs products we Sinoway could supply:

(1) LNB, Lacto-N-Biose

(2) NT II, Lacto-N-triose II

(3) LNT, Lacto-N-tetraose

(4) LNnT, Lacto-N-neotetraose

(5) 2'-fucosyllactose (2'-FL)

If you are interested in any products, please feel free to contact us.